← Open Payments lookup

WILLIAM WALSH: Open Payments

NPI 1730374604 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,583 in 36 payments from 18 companies in 2025. Trend: 2023 $235 · 2024 $1,191 · 2025 $1,583

Food & beverage: $1,484Education: $99
CompanyPaymentsAmount
Indivior Inc.10$245
Edwards Lifesciences Corporation1$202
Corcept Therapeutics2$152
AstraZeneca Pharmaceuticals LP2$138
Phathom Pharmaceuticals, Inc.1$125
Novo Nordisk Inc1$122
Astellas Pharma US Inc2$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$108
GlaxoSmithKline, LLC.2$107
ABBVIE INC.3$55

Products named: SUBLOCADE, SAPIEN 3 Ultra RESILIA, Korlym, VOQUEZNA, Ozempic, CAPLYTA, AREXVY, VRAYLAR.

Industry payments across UT — which companies pay providers there.